AAAAAA

   
Results: 1-10 |
Results: 10
Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor Study
Authors: Sands, SA Kellie, SJ Davidow, AL Diez, B Villablanca, J Weiner, HL Pietanza, MC Balmaceda, C Finlay, JL
Citation: Sa. Sands et al., Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor Study, NEURO-ONCOL, 3(3), 2001, pp. 174-183
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
Authors: Vahdat, L Papadopoulos, K Lange, D Leuin, S Kaufman, E Donovan, D Frederick, D Bagiella, E Tiersten, A Nichols, G Garrett, T Savage, D Antman, K Hesdorffer, CS Balmaceda, C
Citation: L. Vahdat et al., Reduction of paclitaxel-induced peripheral neuropathy with glutamine, CLIN CANC R, 7(5), 2001, pp. 1192-1197
Peripheral neuropathy in cancer patients
Authors: Corbo, M Balmaceda, C
Citation: M. Corbo et C. Balmaceda, Peripheral neuropathy in cancer patients, CANCER INV, 19(4), 2001, pp. 369-382
Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man withtransitional cell carcinoma - A case report
Authors: Prestigiacomo, CJ Balmaceda, C Dalmau, J
Citation: Cj. Prestigiacomo et al., Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man withtransitional cell carcinoma - A case report, CANCER, 91(8), 2001, pp. 1423-1428
Chemotherapy for intramedullary spinal cord tumors
Authors: Balmaceda, C
Citation: C. Balmaceda, Chemotherapy for intramedullary spinal cord tumors, J NEURO-ONC, 47(3), 2000, pp. 293-307
Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel
Authors: Lee, RT Oster, MW Balmaceda, C Hesdorffer, CS Vahdat, LT Papadopoulos, KP
Citation: Rt. Lee et al., Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel, ANN ONCOL, 10(10), 1999, pp. 1245-1247
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors
Authors: Papadopoulos, KP Balmaceda, C Fetell, M Kaufman, E Vahdat, LT Bruce, J Sisti, M Isaacson, S De LaPaz, R Savage, DG Troxel, A Antman, KH Hesdorffer, CS
Citation: Kp. Papadopoulos et al., A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors, J NEURO-ONC, 44(2), 1999, pp. 155-162
Supratentorial ependymomas in adult patients
Authors: Schwartz, TH Kim, S Glick, RS Bagiella, E Balmaceda, C Fetell, MR Stein, BM Sisti, MB Bruce, JN
Citation: Th. Schwartz et al., Supratentorial ependymomas in adult patients, NEUROSURGER, 44(4), 1999, pp. 721-731
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders
Authors: Dalmau, J Gultekin, SH Voltz, R Hoard, R DesChamps, T Balmaceda, C Batchelor, T Gerstner, E Eichen, J Frennier, J Posner, JB Rosenfeld, MR
Citation: J. Dalmau et al., Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders, BRAIN, 122, 1999, pp. 27-39
Chemotherapy for CNS GCTs
Authors: Balmaceda, C Modak, S Finlay, J
Citation: C. Balmaceda et al., Chemotherapy for CNS GCTs, INTRACRANIAL GERM CELL TUMORS, 1998, pp. 243-281
Risultati: 1-10 |